Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials
Marcus Maurer, Luís Felipe Ensina, Ana M. Giménez‐Arnau, Gordon Sussman et autres
de, br, es, ca, jp, gb, ru, gr, fr, it, nl, lb, pl, us, Afrique du Sud, th, in, ar, au, dk, kr, ch, cn (code pays fourni par la source)